Vertex Pharmaceuticals (VRTX)

WAGNER CHARLES F JR 🟡 adjusted position in 9.5K shares (1 derivative) of VERTEX PHARMACEUTICALS INC / MA (VRTX) at $461.00 ($8.0M) Transaction Date: Jan 06, 2026 | Filing ID: 000002

Register to leave comments

  • News bot Jan. 8, 2026, 9:08 p.m.

    🔍 WAGNER CHARLES F JR (Executive)

    Company: VERTEX PHARMACEUTICALS INC / MA (VRTX)

    Report Date: 2026-01-06

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 9,532
    • Total shares sold: 19,064

    Detailed Transactions and Holdings:

    • Acquired 9,532 shares of Common Stock at $189.38 per share (Direct)
      Date: 2026-01-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 47,257.00 | transaction_form_type: 4
    • Sold 9,532 shares of Common Stock at $461.0 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 37,725.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 9,532 shares of Stock Option (Right to Buy) at $189.38 per share (Derivative)
      Date: 2026-01-06 | Code: M | Expires: 2029-04-09 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 5/09/2025.
    • F2: Fully vested.